Primidone Tablet
Product Images NDC 63629-7811

4 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Primidone (NDC 63629-7811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl636297811)

Label Image (Lbl636297811)
Label for Primidone 50 mg oral tablets, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is supplied in a quantity of 30 tablets, with storage instructions to keep at room temperature (20°-25°C). It includes a reference to comparing with Mysoline 50 mg tablets. The label features a barcode and states the product is prescription only.*
FDA Label Image

36e4a4a6-figure-01 (Primidone Tablets Usp 1)

36e4a4a6-figure-01 (Primidone Tablets Usp 1)
Chemical structure of Primidone, showing molecular formula C12H14N2O2 and molecular weight 218.25.*
FDA Label Image

36e4a4a6-figure-02 (Primidone Tablets Usp 2)

36e4a4a6-figure-02 (Primidone Tablets Usp 2)
A data table titled 'Risk by indication for antiepileptic drugs in the pooled analysis' showing the incidence of events per 1000 patients for placebo and drug groups, relative risk, and risk difference across indications including Epilepsy, Psychiatric, Other, and Total categories.*
FDA Label Image

36e4a4a6-figure-03 (Primidone Tablets Usp 3)

36e4a4a6-figure-03 (Primidone Tablets Usp 3)
A dosing schedule table for Primidone tablets, showing dosing instructions by day and time (AM, NOON, PM) for adults and children over 8. It distinguishes between 50 mg and 250 mg tablets with symbols, indicating dose adjustments over a 12-day period leading to maintenance dosing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.